# Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation

> **NCT07090876** · NA · RECRUITING · sponsor: **Indena S.p.A** · enrollment: 60 (estimated)

## Conditions studied

- High-normal Blood Pressure

## Interventions

- **DIETARY_SUPPLEMENT:** Standardized Grape Seed Extract
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07090876
- **Lead sponsor:** Indena S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07090876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07090876, "Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07090876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*